Literature DB >> 7640976

Maggot therapy for treating pressure ulcers in spinal cord injury patients.

R A Sherman1, F Wyle, M Vulpe.   

Abstract

For centuries, maggot therapy (MT) has been recognized as an aid to wound healing. By including live blowfly larvae in wound dressings, earlier physicians noted thorough debridement which hastened wound healing. We initiated a prospective controlled study to evaluate the utility of maggot therapy for treating pressure ulcers in spinal cord injury patients in the modern era. Eight of our patients received MT after a baseline assessment of healing under conventional therapy (defined as any therapy prescribed by the patient's primary care team). Surface area, tissue quality and healing rates were monitored weekly. MT debrided most of the necrotic wounds within one week, which was more rapid than all other non-surgical methods. Wound healing was more rapid during MT than during antecedent conventional therapy (p = 0.01). No complications were seen. We have demonstrated that MT can be beneficial in the treatment of pressure ulcers in persons with spinal cord injuries. MT was significantly more effective and efficient than the current, conventional treatment alternatives being used. MT was also safe, simple and inexpensive. MT can be a valuable modality in the treatment of pressure ulcers.

Entities:  

Mesh:

Year:  1995        PMID: 7640976     DOI: 10.1080/10790268.1995.11719382

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  22 in total

1.  [An historical review of the use of maggots in wound therapy].

Authors:  M Grassberger
Journal:  NTM       Date:  2002

Review 2.  The efficacy of maggot debridement therapy--a review of comparative clinical trials.

Authors:  Kian Zarchi; Gregor B E Jemec
Journal:  Int Wound J       Date:  2012-01-17       Impact factor: 3.315

3.  Assessment of the antimicrobial properties of maggots.

Authors:  Leon Margolin; Philip Gialanella
Journal:  Int Wound J       Date:  2010-04-23       Impact factor: 3.315

4.  Telehealth-guided home-based maggot debridement therapy for chronic complex wounds: Peri- and post-pandemic potential.

Authors:  David G Armstrong; Vincent L Rowe; Karen D'Huyvetter; Ronald A Sherman
Journal:  Int Wound J       Date:  2020-06-18       Impact factor: 3.315

Review 5.  Larval therapy from antiquity to the present day: mechanisms of action, clinical applications and future potential.

Authors:  Iain S Whitaker; Christopher Twine; Michael J Whitaker; Mathew Welck; Charles S Brown; Ahmed Shandall
Journal:  Postgrad Med J       Date:  2007-06       Impact factor: 2.401

Review 6.  Choice of wound care in diabetic foot ulcer: A practical approach.

Authors:  Karakkattu Vijayan Kavitha; Shalbha Tiwari; Vedavati Bharat Purandare; Sudam Khedkar; Shilpa Sameer Bhosale; Ambika Gopalakrishnan Unnikrishnan
Journal:  World J Diabetes       Date:  2014-08-15

7.  Clinical study of Maggot therapy for Fournier's gangrene.

Authors:  Alicia Fonseca-Muñoz; Hugo E Sarmiento-Jiménez; Rafael Pérez-Pacheco; Patricia J Thyssen; Ronald A Sherman
Journal:  Int Wound J       Date:  2020-07-21       Impact factor: 3.315

Review 8.  Maggot therapy takes us back to the future of wound care: new and improved maggot therapy for the 21st century.

Authors:  Ronald A Sherman
Journal:  J Diabetes Sci Technol       Date:  2009-03-01

Review 9.  A systematic review of therapeutic interventions for pressure ulcers after spinal cord injury.

Authors:  Mary Ann Regan; Robert W Teasell; Dalton L Wolfe; David Keast; William B Mortenson; Jo-Anne L Aubut
Journal:  Arch Phys Med Rehabil       Date:  2009-02       Impact factor: 3.966

10.  Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers.

Authors:  Aaron G Paul; Nazni W Ahmad; H L Lee; Ashraff M Ariff; Masri Saranum; Amara S Naicker; Zulkiflee Osman
Journal:  Int Wound J       Date:  2009-02       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.